Bio-Rad CEO -- and Scion -- Norman Schwartz On Growth Strategies | GenomeWeb

Norman Schwartz has literally grown up in the executive suite of Bio-Rad Laboratories. He says he doesn’t remember, but there is a family story about his crib being in the back of the company’s offices.

Today, Schwartz, 54, the son of Bio-Rad Laboratories founders David and Alice Schwartz, is the CEO and president of the 4,800-employee company, which was founded in 1957.

BioCommerce Week spoke to Schwartz this week at the JPMorgan Healthcare Conference in San Francisco about his vision for Bio-Rad’s strategy for growth.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.